for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

BRIEF-GBT Announces Plans To Seek Regulatory Approval For Oxbryta To Treat Sickle Cell Patients In Europe

June 24 (Reuters) - Global Blood Therapeutics Inc:

* GBT ANNOUNCES PLANS TO SEEK REGULATORY APPROVAL FOR OXBRYTA® (VOXELOTOR) TO TREAT SICKLE CELL PATIENTS IN EUROPE

* GLOBAL BLOOD THERAPEUTICS - MARKETING AUTHORIZATION APPLICATION SUBMISSION PLANNED BY MID-2021

* GLOBAL BLOOD THERAPEUTICS INC - ALSO INTENDS TO INITIATE AN EARLY ACCESS PROGRAM IN EUROPE Source text for Eikon: Further company coverage:

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up